Clinical improvement in psoriasis with specific targeting of interleukin-23

Nature
Tamara KoppSauzanne Khalilieh

Abstract

Psoriasis is a chronic inflammatory skin disorder that affects approximately 2-3% of the population worldwide and has severe effects on patients' physical and psychological well-being. The discovery that psoriasis is an immune-mediated disease has led to more targeted, effective therapies; recent advances have focused on the interleukin (IL)-12/23p40 subunit shared by IL-12 and IL-23. Evidence suggests that specific inhibition of IL-23 would result in improvement in psoriasis. Here we evaluate tildrakizumab, a monoclonal antibody that targets the IL-23p19 subunit, in a three-part, randomized, placebo-controlled, sequential, rising multiple-dose phase I study in patients with moderate-to-severe psoriasis to provide clinical proof that specific targeting of IL-23p19 results in symptomatic improvement of disease severity in human subjects. A 75% reduction in the psoriasis area and severity index (PASI) score (PASI75) was achieved by all subjects in parts 1 and 3 (pooled) in the 3 and 10 mg kg(-1) groups by day 196. In part 2, 10 out of 15 subjects in the 3 mg kg(-1) group and 13 out of 14 subjects in the 10 mg kg(-1) group achieved a PASI75 by day 112. Tildrakizumab demonstrated important clinical improvement in moderate-to-severe...Continue Reading

References

Jan 1, 1978·Dermatologica·T Fredriksson, U Pettersson
May 1, 1994·International Journal of Dermatology·D J Trozak
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B HomeyA Zlotnik
Jan 7, 2004·The Journal of Experimental Medicine·Edmund LeeJames G Krueger
May 6, 2005·The New England Journal of Medicine·Michael P Schön, W-Henning Boehncke
Oct 13, 2005·International Archives of Allergy and Immunology·Georg StaryTamara Kopp
Dec 1, 2005·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·S PankuweitB Maisch
Sep 20, 2006·The Journal of Experimental Medicine·Spencer C LiangLynette A Fouser
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eiko ToichiKevin D Cooper
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susan M SaWenjun Ouyang
Feb 23, 2007·Nature·Michelle A LowesJames G Krueger
Aug 9, 2008·The Journal of Clinical Investigation·Hans SkvaraThomas Jung
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emma Guttman-YasskyJames G Krueger
Oct 12, 2010·Science Translational Medicine·Wolfgang HueberFranco Di Padova
Dec 15, 2010·Dermatology : International Journal for Clinical and Investigative Dermatology·Christine BangertGeorg Stingl
Jan 13, 2012·Annals of the New York Academy of Sciences·Jacinta BustamanteJean-Laurent Casanova
Mar 6, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·R G Langley
Jun 9, 2012·The Journal of Allergy and Clinical Immunology·James G KruegerRobert W Hoffman
Jan 11, 2013·The British Journal of Dermatology·K A PappUNKNOWN ACCEPT Investigators
Jan 22, 2013·The British Journal of Dermatology·R R M C KeijsersP C M van de Kerkhof
Aug 21, 2013·Trends in Immunology·Shin Foong NgiowMark J Smyth
Dec 20, 2013·The Journal of Investigative Dermatology·Federica VillanovaFrank O Nestle
Mar 25, 2014·Annual Review of Immunology·Michelle A LowesJames G Krueger

❮ Previous
Next ❯

Citations

Oct 3, 2015·Expert Review of Clinical Immunology·Anna López-FerrerLluís Puig
Sep 4, 2015·Expert Opinion on Biological Therapy·Amanda R van Buul, Christian Taube
Feb 4, 2016·Trends in Molecular Medicine·Audrey BeringerPierre Miossec
Dec 20, 2015·Immunity·Dhavalkumar D Patel, Vijay K Kuchroo
Nov 14, 2015·Annual Review of Medicine·George E FragoulisIain B McInnes
Sep 9, 2015·Journal of Autoimmunity·G J Webb, G M Hirschfield
Nov 14, 2015·Seminars in Immunopathology·Amir S YazdiKamran Ghoreschi
Aug 8, 2015·Journal of Autoimmunity·G J WebbG M Hirschfield
Mar 17, 2016·Science Signaling·Georgina Espígol-FrigoléGiovanna Tosato
Mar 25, 2016·Médecine sciences : M/S·Adèle de MassonArmand Bensussan
Jun 26, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Martin Röcken
Apr 15, 2016·Clinical Rheumatology·Siba P Raychaudhuri, Smriti K Raychaudhuri
Feb 11, 2016·Inflammatory Bowel Diseases·Mei Lan Chen, Mark S Sundrud
May 8, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Patricia R TaylorEric Pearlman
May 31, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Sebastian Volc, Kamran Ghoreschi
May 31, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Sebastian Volc, Kamran Ghoreschi
Jun 30, 2016·Expert Opinion on Therapeutic Targets·Markus JoergerSteven G Gray
Oct 23, 2016·Drug Discovery Today. Technologies·Srimoyee Ghosh, Jose M Lora
Jan 23, 2016·Annales de dermatologie et de vénéréologie·H Bachelez
Oct 18, 2016·Journal of the American Academy of Dermatology·Doris WeissChristine Bangert
Nov 23, 2016·Current Opinion in Rheumatology·Helen Alexander, Frank O Nestle
Mar 9, 2017·Expert Opinion on Biological Therapy·Marco GalluzzoMarina Talamonti
Feb 9, 2017·Photodermatology, Photoimmunology & Photomedicine·Joselin D TacastacasThomas S McCormick
May 4, 2017·Expert Opinion on Drug Metabolism & Toxicology·M GalluzzoL Bianchi
Sep 18, 2016·The British Journal of Dermatology·A BlauveltJ J Wu
Jan 4, 2017·Expert Opinion on Investigational Drugs·Zenas Z N Yiu, Richard B Warren
May 31, 2017·European Journal of Immunology·Katharina WelschKamran Ghoreschi
Jun 18, 2017·The Nurse Practitioner·Wendy Cantrell
Mar 31, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jérôme C MartinRégis Josien
Oct 11, 2017·Dermatologic Therapy·Dominika Wcisło-DziadeckaAgata Kaźmierczak
Jun 6, 2018·Current Opinion in Allergy and Clinical Immunology·Yael Renert-Yuval, Emma Guttman-Yassky
Jun 28, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·G GirolomoniJ C Prinz
Aug 8, 2018·Immunotherapy·Christine Bangert, Tamara Kopp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.